METASTASES TO THYROID

This adverse event was reported 92 times

These drugs are most commonly taken by patients reporting METASTASES TO THYROID:

# Drug Count
0 OCTREOTIDE ACETATE 12
1 CAPECITABINE 8
2 MOXIFLOXACIN 8
3 MOXIFLOXACIN HYDROCHLORIDE 8
4 ANASTROZOLE 7
5 ANASTROZOLE TABLETS 7
6 RIBOCICLIB 7
7 CARBOPLATIN 6
8 FULVESTRANT 6
9 LETROZOLE 6
See all common drugs associated with METASTASES TO THYROID

METASTASES TO THYROID is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LEVAMLODIPINE 1 0.0080
1 HYDROQUINONE 1 0.0017
2 ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) 2 0.0009
3 TOPOTECAN 3 0.0005
4 NERATINIB 1 0.0004
5 TRABECTEDIN 1 0.0004
6 OCTREOTIDE ACETATE 12 0.0004
7 MOXIFLOXACIN HYDROCHLORIDE 8 0.0004
8 LANREOTIDE ACETATE 3 0.0004
9 CALCITONIN SALMON 1 0.0003
See all drugs enriched for association with METASTASES TO THYROID

METASTASES TO THYROID is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Melanin Synthesis Inhibitor [EPC] 1 0.0009
1 Calcitonin [EPC] 1 0.0003
2 Estrogen Receptor Antagonist [EPC] 6 0.0001
3 Somatostatin Analog [EPC] 1 0.0001
4 Vitamin K [EPC] 1 0.0001
5 Aromatase Inhibitor [EPC] 10 0.0001
6 Barbiturate [EPC] 1 0.0001
7 Programmed Death Receptor-1 Blocking Antibody [EPC] 6 0.0001
8 Nitrofuran Antibacterial [EPC] 1 0.0001
9 Topoisomerase Inhibitor [EPC] 4 0.0001
See all drug classes enriched for association with METASTASES TO THYROID